Vivos Therapeutics, Inc. Payments of Derivative Issuance Costs
Vivos Therapeutics, Inc. (VVOS) reported Payments of Derivative Issuance Costs of $645.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDerivativeIssuanceCosts · last filed 2023-08-16
- Vivos Therapeutics, Inc. payments of derivative issuance costs for the quarter ending 2023-06-30 was $0.00.
- Vivos Therapeutics, Inc. payments of derivative issuance costs for the quarter ending 2023-03-31 was $645.00K.
| Period end | Payments of Derivative Issuance Costs 3 month | Payments of Derivative Issuance Costs 6 month |
|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | $645.00K 10-Q · filed 2023-08-16 |
| 2023-03-31 | $645.00K 10-Q · filed 2023-06-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |